• Home
  • Investors
    • News Archive
    • Share Information
      • Shareholder Service
      • General Meetings
    • Reports
    • Board and Management
  • Contact

You are here

Home » Investors

News

The results for Q1 2008 - Sales growth in the infectious diseases segment
NorDiag acquires exclusive rights to infectious disease technology platform
NorDiag expands collaboration with EXACT Sciences for joint development of colorectal cancer screening technologies
Presentation of the first quarter 2008
Protocol from Annual General Meeting
Annual overview
Notice of General Meeting
Financial Statements 2007
News from NorDiag's collaboration partner
Q4 2007 Reporting NorDiag ASA
Presentation of the fourth quarter 2007
Extraordinary General Meeting
Presentation in today's Extraordinary General Meeting
Disclosure of Power of Attorneys
Notice of Extra Ordinary General Meeting
Change in NorDiag ASA's Board of Directors
Calendar of Finance 2008
NorDiag Q3 2007
Presentation of the third quarter 2007
Allotted share options

Pages

  • « first
  • ‹ previous
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • next ›
  • last »
News archive

NORDA ASA  ♦  P.O. Box 1666 Vika  ♦   0110 Oslo  ♦   Norway  ♦   Phone: +47 92 42 35 61  ♦   web: www.nordasa.no